BlackRock’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-54,721
| Closed | -$138K | – | 5250 |
|
|
2020
Q2 | $138K | Sell |
54,721
-15,078
| -22% | -$28.6K | ﹤0.01% | 4439 |
|
|
2020
Q1 | $89K | Buy |
69,799
+11,757
| +20% | +$24K | ﹤0.01% | 4369 |
|
|
2019
Q4 | $163K | Sell |
58,042
-3,737
| -6% | -$12K | ﹤0.01% | 4357 |
|
|
2019
Q3 | $328K | Sell |
61,779
-1,590
| -3% | -$10.6K | ﹤0.01% | 4245 |
|
|
2019
Q2 | $608K | Sell |
63,369
-123,541
| -66% | -$2.27M | ﹤0.01% | 4146 |
|
|
2019
Q1 | $5.01M | Sell |
186,910
-4,609
| -2% | -$117K | ﹤0.01% | 3412 |
|
|
2018
Q4 | $4.33M | Sell |
191,519
-24,294
| -11% | -$950K | ﹤0.01% | 3438 |
|
|
2018
Q3 | $11.9M | Buy |
215,813
+7,197
| +3% | +$460K | ﹤0.01% | 3146 |
|
|
2018
Q2 | $14.9M | Buy |
208,616
+7,494
| +4% | +$529K | ﹤0.01% | 3030 |
|
|
2018
Q1 | $12.3M | Sell |
201,122
-1,095
| -0.5% | -$96.1K | ﹤0.01% | 3021 |
|
|
2017
Q4 | $25.5M | Buy |
202,217
+35,365
| +21% | +$4.53M | ﹤0.01% | 2659 |
|
|
2017
Q3 | $22.8M | Buy |
166,852
+48,425
| +41% | +$6.48M | ﹤0.01% | 2732 |
|
|
2017
Q2 | $16.9M | Buy |
118,427
+3,392
| +3% | +$524K | ﹤0.01% | 2885 |
|
|
2017
Q1 | $21.1M | Buy |
115,035
+114,654
| +30,093% | +$12.9M | ﹤0.01% | 2724 |
|
|
2016
Q4 | $30K | Sell |
381
-32
| -8% | -$2.53K | ﹤0.01% | 3138 |
|
|
2016
Q3 | $32K | Hold |
413
| – | – | ﹤0.01% | 3149 |
|
|
2016
Q2 | $35K | Buy |
413
+287
| +228% | +$26.3K | ﹤0.01% | 3087 |
|
|
2016
Q1 | $12K | Sell |
126
-40
| -24% | -$4K | ﹤0.01% | 3092 |
|
|
2015
Q4 | $33K | Buy |
166
+88
| +113% | +$17.6K | ﹤0.01% | 2304 |
|
|
2015
Q3 | $12K | Buy |
78
+24
| +44% | +$17.6K | ﹤0.01% | 2658 |
|
|
2015
Q2 | $51K | Buy |
54
+20
| +59% | +$16.4K | ﹤0.01% | 1975 |
|
|
2015
Q1 | $25K | Buy |
34
+5
| +17% | +$3.76K | ﹤0.01% | 2256 |
|
|
2014
Q4 | $23K | Hold |
29
| – | – | ﹤0.01% | 2307 |
|
|
2014
Q3 | $12K | Hold |
29
| – | – | ﹤0.01% | 2628 |
|
|
2014
Q2 | $8K | Buy |
29
+3
| +12% | +$644 | ﹤0.01% | 2955 |
|
|
2014
Q1 | $6K | Buy |
26
+7
| +37% | +$1.95K | ﹤0.01% | 3025 |
|
|
2013
Q4 | $5K | Buy |
+19
| New | +$4.53K | ﹤0.01% | 3058 |
|
BlackRock's TTPH Position: Q3 2020 in Review
BlackRock sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 54,721 shares — an estimated $138K sold.
BlackRock first reported a position in TTPH in Q4 2013 and held it in 27 quarters. The position peaked at $25.5M in Q4 2017. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.
- BlackRock reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- BlackRock sold 54,721 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $138K.
- BlackRock first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2013 and held it in 27 quarters.
- BlackRock's Tetraphase Pharmaceuticals, Inc. position peaked at $25.5M in Q4 2017.
- 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.
Based on BlackRock's 13F filing for Q3 2020, filed 6 Nov 2020.